With the help of TEAM BEV, we just funded 4 research projects from the funds raised during 2017. Collectively as a team, your donations and support are helping scientists dive in to study this disease and look for a cure for generations to come. THANK YOU!
- $100,000 – to Scripps Research Institute – Matt Disney – They have a series of compounds that they believe are brain entrant that affect many aspects of HD by targeting the CAG repeat. They are near a real breakthrough and will use our funds to see if the compound can indeed be a breakthrough to treat HD.
- $100,000 – to Oregon Health & Science Univ. – Jodi McBride (we funded her in 2015) – They have 3 significant ongoing projects that are using the monkey models that were developed with our funding in 2015.
- $100,000 – to Massachusetts Institute of Technology – Myriam Heiman – Study of two genes that they believe regulate the toxic accumulation of mutant Huntingtin in the brain. Our funding would allow them to perform the necessary therapeutic test studies in mice.
- $50,000 – to Glycoscience Research – Larry Holler – continuing to work to get GM1 to clinical trials (we funded them in 2016)